Neurodegenerative Disease

Vesalius, GSK announce strategic alliance on neurodegenerative disease treatments
By LabPulse.com staff writers
Biotech firm Vesalius Therapeutics announced a strategic collaboration with GSK aimed at the discovery and development of therapeutics for Parkinson's disease and another undisclosed neurodegenerative disease.
November 15, 2024
Parkinsons Neuron Social
Target ALS launches new data portal for research
By Matt Limb
A nonprofit medical research foundation has launched a data portal designed to help spur scientific breakthroughs for the disease amyotrophic lateral sclerosis (ALS).
April 23, 2024
Dna Data Ai Social
Skin biopsy test shows promise for detection of neurogenerative diseases
By Matt Limb
A simple skin biopsy test has shown a high accuracy rate in detecting an abnormal form of alpha-synuclein, the pathological hallmark of Parkinson's disease and other synucleinopathies, say neurologists.
April 5, 2024
Parkinsons Neuron Social
U.K. team develops new approach to detect signs of motor neuron disease
By Matt Limb
Scientists have identified a new way to detect signs of motor neuron disease (MND) in brain tissue, raising hopes for early diagnosis and intervention before onset of symptoms.
April 3, 2024
Nerve Neuron Axon Social
Myrobalan Therapeutics completes $24M series A financing round
By LabPulse.com staff writers
Biotech company Myrobalan Therapeutics completed a $24 million series A financing round Wednesday.
January 11, 2024
Research Money Social
CRISPR-Cas3 technique restores dystrophin function in iPSCs from DMD patients
By Maryam Payne
Researchers have developed a dual CRISPR-Cas3 gene editing technique to restore dystrophin function in induced pluripotent stem cells (iPSCs) from patients with Duchenne muscular dystrophy (DMD).
August 24, 2023
This photo shows green dystrophin protein restored by dual-Cas3 in skeletal muscle derived from DMD patient iPSCs.
Scientists discover genetic variant linked to speed of multiple sclerosis progression
By Nick Paul Taylor
The analysis of seven million genetic variants enabled the scientists to identify a variant associated with faster disease progression.
June 30, 2023
Dna Genome Gene Targeted Social
Gut bacteria changes in preclinical Alzheimer’s suggest ways to detect, delay disease
By Nick Paul Taylor
Earlier studies found that the gut microbiomes of people with symptomatic Alzheimer’s differ from those of healthy people of the same age, but were unable to tell how early the divergence begins.
June 14, 2023
Alzheimers Phases Amyloid Social
Serum assay may enable the diagnosis of neurodegenerative diseases
By Elissa Wolfson
An assay that detects minute concentrations of alpha synuclein seeds in blood serum may enable quicker diagnosis of neurodegenerative disorders.
May 30, 2023
Blood Test Samples Lab Social
CND Life Sciences closes $4.5M seed financing round
By LabPulse.com staff writers
The funding is intended to accelerate the commercialization of the Syn-One test that identifies abnormal alpha-synuclein aggregation in cutaneous nerves through a skin biopsy.
April 6, 2023
Research Money Social
CND Life Sciences, Beth Israel sign agreement on skin-based testing technology for neurodegenerative diseases
By LabPulse.com staff writers
The agreement with Beth Israel Deaconess Medical Center aims to solidify important technology for CND’s Syn-One Test, a skin-based test that aids the diagnosis of synucleinopathies, a family of neurodegenerative disorders.
March 22, 2023
Brain Puzzle Dementia Social
Fluorescent RNA enables real time detection of neurodegenerative disease driver in live cells
By Nick Paul Taylor
Researchers have found an RNA structure associated with a neurodegenerative disease in live cells using a technique based on fluorescence-microscopic spectroscopy.
February 7, 2023
Brain Puzzle Dementia
Page 1 of 2
Next Page